Publication

Article

Oncology Fellows
December 2011
Volume 3
Issue 4

What US Oncologists Are Earning: Medscape's 2011 Report

Author(s):

You might be struck by the seemingly odd distribution of oncology salaries in the United States. Why would oncologists in the Mid-Atlantic region, where the cost of living is relatively high, have lower median salaries than the North Central region, where the cost of living is lower?

At first glance, you might be struck by the seemingly odd distribution of oncology salaries in the United States. For example, why would oncologists in the Mid-Atlantic region, where the cost of living is relatively high, have lower median salaries than the North Central region, where the cost of living is lower? According to Medscape’s 2011 report, it is due to the higher concentration of research hospitals and community oncology practices in the Northeast, Mid-Atlantic, and West. These institutions increase the competition for oncology positions and thus lower the median salaries.

Related Videos
In this episode of OncChats: Optimizing the Use of Bispecific Antibodies in Myeloma and Beyond, Drs Usmani and Wasil emphasize the need for comprehensive patient education, effective communication, and specific safety protocols to manage patients receiving bispecific T-cell engagers.
In this episode of OncChats: Optimizing the Use of Bispecific Antibodies in Myeloma and Beyond, Drs Usmani and Wasil discuss the challenges and strategies in managing bispecific T-cell engagers in the realm of cancer, emphasizing the importance of community and tertiary care collaboration to handle unique toxicities like cytokine release syndrome (CRS) and the need for well-defined protocols to ensure patient safety and effective treatment.
In this episode of OncChats: Optimizing the Use of Bispecific Antibodies in Myeloma and Beyond, Drs Usmani and Wasil discuss bispecific T-cell engagers, highlighting their effectiveness in treating hematologic malignancies like multiple myeloma, their potential use in solid tumors, and the importance of managing unique adverse effects, such as cytokine release syndrome and infection risks.
Jorge E. Cortes, MD
Nicolas Girard, MD
Sunil Adige, MD
Minoo Battiwalla, MD, MS